DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Ventricular Assist Device (VAD) Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2014-2022" report to their offering.
The market for VAD is expected to reach around USD 2.5 billion by 2022, growing at a CAGR of 15.2% during the forecast period of 2016e to 2022f.
However, there are certain restraining factors which could hamper the growth of the market, which includes, high costs associated with the VAD implantation compared to other therapies available for CVD diseases and other serious complications such as severe bleeding. Immunosuppression, etc.
Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to increasing prevalence of CVD diseases, growing awareness among the population, improving healthcare infrastructure, rise in healthcare spending, and favorable government policies.
The company profile section include detailed analysis of some of the key players such as Abiomed, Heart Ware International Inc., St Jude Medical, Berlin Heart GmbH, Apaxis, Inc., ReliantHeart, Sun Medical Technology Research, Terumo Corporation
Key Topics Covered:
1 Scope of the report
2 Executive summary
3 Qualitative analysis
4 Global VAD market, by type of indication, 2014-2022f
6 Company profiles
- Apaxis Inc.
- Berlin Heart GmbH
- Heart Ware International Inc.
- St Jude Medical
- Sun Medical Technology Research
- Terumo Corporation
For more information about this report visit http://www.researchandmarkets.com/research/flk5k6/ventricular